Research ArticleArticle
Prevalence of Anti-Peptidylarginine Deiminase Type 4 Antibodies in Rheumatoid Arthritis and Unaffected First-degree Relatives in Indigenous North American Populations
Elizabeth D. Ferucci, Erika Darrah, Irene Smolik, Tammy L. Choromanski, David B. Robinson, Marianna M. Newkirk, Marvin J. Fritzler, Antony Rosen and Hani S. El-Gabalawy
The Journal of Rheumatology August 2013, jrheum.130293; DOI: https://doi.org/10.3899/jrheum.130293
Elizabeth D. Ferucci
From the Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Medicine, University of Manitoba, Winnipeg, Manitoba; Department of Medicine, McGill University Health Centre, Montreal, Quebec; and Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Supported by the Canadian Institutes of Health Research, grant MOP 7770 (Dr. El-Gabalawy), the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number P30AR053503, the Sibley Memorial Hospital grant (Drs. Darrah and Rosen), and NIH grant T32 AR048522 (Dr. Darrah). E.D. Ferucci, MD, MPH, Division of Community Health Services, Alaska Native Tribal Health Consortium; E. Darrah, PhD, Department of Medicine, Johns Hopkins University School of Medicine; I. Smolik, PhD, Department of Medicine, University of Manitoba; T.L. Choromanski, BS, Division of Community Health Services, Alaska Native Tribal Health Consortium; D.B. Robinson, MD, FRCPC, Department of Medicine, University of Manitoba; M.M. Newkirk, PhD, Department of Medicine, McGill University Health Centre; M.J. Fritzler, MD, PhD, Department of Medicine, University of Calgary; A. Rosen, MB ChB, Department of Medicine, Johns Hopkins University School of Medicine; H.S. El-Gabalawy, MD, FRCPC, Department of Medicine, University of Manitoba. Address correspondence to Dr. H. S. El-Gabalawy, University of Manitoba Arthritis Centre, RR149-800 Sherbrook Street, Winnipeg, Manitoba R3A 1M4, Canada. E-mail: Hani.Elgabalawy@med.umanitoba.ca. Accepted for publication May 13, 2013.
Erika Darrah
From the Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Medicine, University of Manitoba, Winnipeg, Manitoba; Department of Medicine, McGill University Health Centre, Montreal, Quebec; and Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Supported by the Canadian Institutes of Health Research, grant MOP 7770 (Dr. El-Gabalawy), the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number P30AR053503, the Sibley Memorial Hospital grant (Drs. Darrah and Rosen), and NIH grant T32 AR048522 (Dr. Darrah). E.D. Ferucci, MD, MPH, Division of Community Health Services, Alaska Native Tribal Health Consortium; E. Darrah, PhD, Department of Medicine, Johns Hopkins University School of Medicine; I. Smolik, PhD, Department of Medicine, University of Manitoba; T.L. Choromanski, BS, Division of Community Health Services, Alaska Native Tribal Health Consortium; D.B. Robinson, MD, FRCPC, Department of Medicine, University of Manitoba; M.M. Newkirk, PhD, Department of Medicine, McGill University Health Centre; M.J. Fritzler, MD, PhD, Department of Medicine, University of Calgary; A. Rosen, MB ChB, Department of Medicine, Johns Hopkins University School of Medicine; H.S. El-Gabalawy, MD, FRCPC, Department of Medicine, University of Manitoba. Address correspondence to Dr. H. S. El-Gabalawy, University of Manitoba Arthritis Centre, RR149-800 Sherbrook Street, Winnipeg, Manitoba R3A 1M4, Canada. E-mail: Hani.Elgabalawy@med.umanitoba.ca. Accepted for publication May 13, 2013.
Irene Smolik
From the Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Medicine, University of Manitoba, Winnipeg, Manitoba; Department of Medicine, McGill University Health Centre, Montreal, Quebec; and Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Supported by the Canadian Institutes of Health Research, grant MOP 7770 (Dr. El-Gabalawy), the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number P30AR053503, the Sibley Memorial Hospital grant (Drs. Darrah and Rosen), and NIH grant T32 AR048522 (Dr. Darrah). E.D. Ferucci, MD, MPH, Division of Community Health Services, Alaska Native Tribal Health Consortium; E. Darrah, PhD, Department of Medicine, Johns Hopkins University School of Medicine; I. Smolik, PhD, Department of Medicine, University of Manitoba; T.L. Choromanski, BS, Division of Community Health Services, Alaska Native Tribal Health Consortium; D.B. Robinson, MD, FRCPC, Department of Medicine, University of Manitoba; M.M. Newkirk, PhD, Department of Medicine, McGill University Health Centre; M.J. Fritzler, MD, PhD, Department of Medicine, University of Calgary; A. Rosen, MB ChB, Department of Medicine, Johns Hopkins University School of Medicine; H.S. El-Gabalawy, MD, FRCPC, Department of Medicine, University of Manitoba. Address correspondence to Dr. H. S. El-Gabalawy, University of Manitoba Arthritis Centre, RR149-800 Sherbrook Street, Winnipeg, Manitoba R3A 1M4, Canada. E-mail: Hani.Elgabalawy@med.umanitoba.ca. Accepted for publication May 13, 2013.
Tammy L. Choromanski
From the Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Medicine, University of Manitoba, Winnipeg, Manitoba; Department of Medicine, McGill University Health Centre, Montreal, Quebec; and Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Supported by the Canadian Institutes of Health Research, grant MOP 7770 (Dr. El-Gabalawy), the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number P30AR053503, the Sibley Memorial Hospital grant (Drs. Darrah and Rosen), and NIH grant T32 AR048522 (Dr. Darrah). E.D. Ferucci, MD, MPH, Division of Community Health Services, Alaska Native Tribal Health Consortium; E. Darrah, PhD, Department of Medicine, Johns Hopkins University School of Medicine; I. Smolik, PhD, Department of Medicine, University of Manitoba; T.L. Choromanski, BS, Division of Community Health Services, Alaska Native Tribal Health Consortium; D.B. Robinson, MD, FRCPC, Department of Medicine, University of Manitoba; M.M. Newkirk, PhD, Department of Medicine, McGill University Health Centre; M.J. Fritzler, MD, PhD, Department of Medicine, University of Calgary; A. Rosen, MB ChB, Department of Medicine, Johns Hopkins University School of Medicine; H.S. El-Gabalawy, MD, FRCPC, Department of Medicine, University of Manitoba. Address correspondence to Dr. H. S. El-Gabalawy, University of Manitoba Arthritis Centre, RR149-800 Sherbrook Street, Winnipeg, Manitoba R3A 1M4, Canada. E-mail: Hani.Elgabalawy@med.umanitoba.ca. Accepted for publication May 13, 2013.
David B. Robinson
From the Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Medicine, University of Manitoba, Winnipeg, Manitoba; Department of Medicine, McGill University Health Centre, Montreal, Quebec; and Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Supported by the Canadian Institutes of Health Research, grant MOP 7770 (Dr. El-Gabalawy), the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number P30AR053503, the Sibley Memorial Hospital grant (Drs. Darrah and Rosen), and NIH grant T32 AR048522 (Dr. Darrah). E.D. Ferucci, MD, MPH, Division of Community Health Services, Alaska Native Tribal Health Consortium; E. Darrah, PhD, Department of Medicine, Johns Hopkins University School of Medicine; I. Smolik, PhD, Department of Medicine, University of Manitoba; T.L. Choromanski, BS, Division of Community Health Services, Alaska Native Tribal Health Consortium; D.B. Robinson, MD, FRCPC, Department of Medicine, University of Manitoba; M.M. Newkirk, PhD, Department of Medicine, McGill University Health Centre; M.J. Fritzler, MD, PhD, Department of Medicine, University of Calgary; A. Rosen, MB ChB, Department of Medicine, Johns Hopkins University School of Medicine; H.S. El-Gabalawy, MD, FRCPC, Department of Medicine, University of Manitoba. Address correspondence to Dr. H. S. El-Gabalawy, University of Manitoba Arthritis Centre, RR149-800 Sherbrook Street, Winnipeg, Manitoba R3A 1M4, Canada. E-mail: Hani.Elgabalawy@med.umanitoba.ca. Accepted for publication May 13, 2013.
Marianna M. Newkirk
From the Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Medicine, University of Manitoba, Winnipeg, Manitoba; Department of Medicine, McGill University Health Centre, Montreal, Quebec; and Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Supported by the Canadian Institutes of Health Research, grant MOP 7770 (Dr. El-Gabalawy), the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number P30AR053503, the Sibley Memorial Hospital grant (Drs. Darrah and Rosen), and NIH grant T32 AR048522 (Dr. Darrah). E.D. Ferucci, MD, MPH, Division of Community Health Services, Alaska Native Tribal Health Consortium; E. Darrah, PhD, Department of Medicine, Johns Hopkins University School of Medicine; I. Smolik, PhD, Department of Medicine, University of Manitoba; T.L. Choromanski, BS, Division of Community Health Services, Alaska Native Tribal Health Consortium; D.B. Robinson, MD, FRCPC, Department of Medicine, University of Manitoba; M.M. Newkirk, PhD, Department of Medicine, McGill University Health Centre; M.J. Fritzler, MD, PhD, Department of Medicine, University of Calgary; A. Rosen, MB ChB, Department of Medicine, Johns Hopkins University School of Medicine; H.S. El-Gabalawy, MD, FRCPC, Department of Medicine, University of Manitoba. Address correspondence to Dr. H. S. El-Gabalawy, University of Manitoba Arthritis Centre, RR149-800 Sherbrook Street, Winnipeg, Manitoba R3A 1M4, Canada. E-mail: Hani.Elgabalawy@med.umanitoba.ca. Accepted for publication May 13, 2013.
Marvin J. Fritzler
From the Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Medicine, University of Manitoba, Winnipeg, Manitoba; Department of Medicine, McGill University Health Centre, Montreal, Quebec; and Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Supported by the Canadian Institutes of Health Research, grant MOP 7770 (Dr. El-Gabalawy), the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number P30AR053503, the Sibley Memorial Hospital grant (Drs. Darrah and Rosen), and NIH grant T32 AR048522 (Dr. Darrah). E.D. Ferucci, MD, MPH, Division of Community Health Services, Alaska Native Tribal Health Consortium; E. Darrah, PhD, Department of Medicine, Johns Hopkins University School of Medicine; I. Smolik, PhD, Department of Medicine, University of Manitoba; T.L. Choromanski, BS, Division of Community Health Services, Alaska Native Tribal Health Consortium; D.B. Robinson, MD, FRCPC, Department of Medicine, University of Manitoba; M.M. Newkirk, PhD, Department of Medicine, McGill University Health Centre; M.J. Fritzler, MD, PhD, Department of Medicine, University of Calgary; A. Rosen, MB ChB, Department of Medicine, Johns Hopkins University School of Medicine; H.S. El-Gabalawy, MD, FRCPC, Department of Medicine, University of Manitoba. Address correspondence to Dr. H. S. El-Gabalawy, University of Manitoba Arthritis Centre, RR149-800 Sherbrook Street, Winnipeg, Manitoba R3A 1M4, Canada. E-mail: Hani.Elgabalawy@med.umanitoba.ca. Accepted for publication May 13, 2013.
Antony Rosen
From the Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Medicine, University of Manitoba, Winnipeg, Manitoba; Department of Medicine, McGill University Health Centre, Montreal, Quebec; and Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Supported by the Canadian Institutes of Health Research, grant MOP 7770 (Dr. El-Gabalawy), the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number P30AR053503, the Sibley Memorial Hospital grant (Drs. Darrah and Rosen), and NIH grant T32 AR048522 (Dr. Darrah). E.D. Ferucci, MD, MPH, Division of Community Health Services, Alaska Native Tribal Health Consortium; E. Darrah, PhD, Department of Medicine, Johns Hopkins University School of Medicine; I. Smolik, PhD, Department of Medicine, University of Manitoba; T.L. Choromanski, BS, Division of Community Health Services, Alaska Native Tribal Health Consortium; D.B. Robinson, MD, FRCPC, Department of Medicine, University of Manitoba; M.M. Newkirk, PhD, Department of Medicine, McGill University Health Centre; M.J. Fritzler, MD, PhD, Department of Medicine, University of Calgary; A. Rosen, MB ChB, Department of Medicine, Johns Hopkins University School of Medicine; H.S. El-Gabalawy, MD, FRCPC, Department of Medicine, University of Manitoba. Address correspondence to Dr. H. S. El-Gabalawy, University of Manitoba Arthritis Centre, RR149-800 Sherbrook Street, Winnipeg, Manitoba R3A 1M4, Canada. E-mail: Hani.Elgabalawy@med.umanitoba.ca. Accepted for publication May 13, 2013.
Hani S. El-Gabalawy
From the Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Medicine, University of Manitoba, Winnipeg, Manitoba; Department of Medicine, McGill University Health Centre, Montreal, Quebec; and Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Supported by the Canadian Institutes of Health Research, grant MOP 7770 (Dr. El-Gabalawy), the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number P30AR053503, the Sibley Memorial Hospital grant (Drs. Darrah and Rosen), and NIH grant T32 AR048522 (Dr. Darrah). E.D. Ferucci, MD, MPH, Division of Community Health Services, Alaska Native Tribal Health Consortium; E. Darrah, PhD, Department of Medicine, Johns Hopkins University School of Medicine; I. Smolik, PhD, Department of Medicine, University of Manitoba; T.L. Choromanski, BS, Division of Community Health Services, Alaska Native Tribal Health Consortium; D.B. Robinson, MD, FRCPC, Department of Medicine, University of Manitoba; M.M. Newkirk, PhD, Department of Medicine, McGill University Health Centre; M.J. Fritzler, MD, PhD, Department of Medicine, University of Calgary; A. Rosen, MB ChB, Department of Medicine, Johns Hopkins University School of Medicine; H.S. El-Gabalawy, MD, FRCPC, Department of Medicine, University of Manitoba. Address correspondence to Dr. H. S. El-Gabalawy, University of Manitoba Arthritis Centre, RR149-800 Sherbrook Street, Winnipeg, Manitoba R3A 1M4, Canada. E-mail: Hani.Elgabalawy@med.umanitoba.ca. Accepted for publication May 13, 2013.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Prevalence of Anti-Peptidylarginine Deiminase Type 4 Antibodies in Rheumatoid Arthritis and Unaffected First-degree Relatives in Indigenous North American Populations
Elizabeth D. Ferucci, Erika Darrah, Irene Smolik, Tammy L. Choromanski, David B. Robinson, Marianna M. Newkirk, Marvin J. Fritzler, Antony Rosen, Hani S. El-Gabalawy
The Journal of Rheumatology Aug 2013, jrheum.130293; DOI: 10.3899/jrheum.130293
Prevalence of Anti-Peptidylarginine Deiminase Type 4 Antibodies in Rheumatoid Arthritis and Unaffected First-degree Relatives in Indigenous North American Populations
Elizabeth D. Ferucci, Erika Darrah, Irene Smolik, Tammy L. Choromanski, David B. Robinson, Marianna M. Newkirk, Marvin J. Fritzler, Antony Rosen, Hani S. El-Gabalawy
The Journal of Rheumatology Aug 2013, jrheum.130293; DOI: 10.3899/jrheum.130293